Aquestive Therapeutics, Inc. (17) | Intellectual Property (2)
- Second Amendment to License Agreement, by and between Aquestive Therapeutics, Inc. and Sunovion Pharmaceuticals, Inc., dated as of October 23, 2020 (Filed With SEC on March 9, 2021)
- First Amendment to License Agreement, effective as of March 16, 2020, by and between Aquestive Therapeutics, Inc. and Sunovion Pharmaceuticals Inc. (formerly, Cynapsus... (Filed With SEC on March 20, 2020)
